Immune Profiling Core
免疫分析核心
基本信息
- 批准号:10649944
- 负责人:
- 金额:$ 26.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-15 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adjuvant TherapyAntibodiesAntigensAutopsyB-LymphocytesBiological AssayBiological Specimen BanksBiopsyBody FluidsCell DeathCellsChairpersonClinicalColorCommunicable DiseasesCore FacilityCryopreservationCytomegalovirusDiseaseEnvironmentFlow CytometryGoalsGraft RejectionHealthHistologyHumanHuman Herpesvirus 4ImmuneImmunityImmunizationImmunoassayImmunocompromised HostImmunohistochemistryImmunologicsImmunology procedureImmunosuppressionIndividualInfrastructureKidney TransplantationKnowledgeLaboratoriesLasersLeadLeadershipLymphocryptovirusMacaca mulattaManagement Information SystemsMemory B-LymphocyteMonitorOperative Surgical ProceduresOrganPatientsPeripheral Blood Mononuclear CellPhenotypePlasmaPlasma CellsPositioning AttributePre-Clinical ModelPrior TherapyProceduresProteasome InhibitionRegimenRegulationResearchResearch SupportResource SharingRhesusRiskSafetySamplingScientistSerumServicesSimian virus 40SirolimusSpecimenSpecimen HandlingStainsStandardizationStructure of germinal center of lymph nodeSupervisionT-LymphocyteTechnical ExpertiseTestingThymus GlandTissue SampleTissuesTransplantationTransplantation ImmunologyUniversitiesViralViral AntigensVirus LatencyWorkallotransplantbasebiobankclinically relevantcytokinedesensitizationdigitalexhaustionimprovedinstrumentkidney allograftlaboratory experiencelymph nodesmedical schoolsnonhuman primatenovel therapeutic interventionpost-transplantpreservationpreventprogramsquality assuranceresearch studysecondary lymphoid organside effectsingle cell analysissynergismtesting services
项目摘要
Immune Profiling Core The Immune Profiling Core (IPC) will provide comprehensive technical assay support services for the hypothesis-driven research studies proposed in the two Projects comprising this U19 proposal. The Core derives its greatest overall strength from the relevant expertise, organization, procedures, and operational synergy of its components. Anchoring these efforts is the Duke Immune Profiling Core (DIPC), a Duke School of Medicine Shared Resource that has been in existence since 1988. Largely focused on flow cytometry-based platforms for human immune profiling, the Core has actively participated in external proficiency testing and quality assurance programs for over 25 years. Assay testing is performed in a Good Clinical Laboratory (GCLP)-compliant environment according to highly standardized and validated Standard Operating Procedures (SOPs). The Core is joined in its efforts by a support team of highly experienced laboratory professionals from the Kirk and Knechtle research Cores who have recently re-located to Duke from Emory University. These individuals have extensive expertise in all aspects of transplantation research, both in human and nonhuman primate (NHP) studies. The key services the IPC will provide to Projects 1 and 2 include: 1) state-of-the-art specimen processing and biobanking, 2) analytical polychromatic flow cytometry (PFC) phenotyping, and intracellular cytokine staining (ICCS), 3) virologic testing, and 4) comprehensive histology and immunohistochemistry support. The IPC is well positioned to provide PFC services to the projects under this proposal; PFC having been the technical mainstay of the research endeavors of the DIPC. The present core facility houses a 4-laser BD LSRII, 5-laser BD LSRFortessa, 5-laser BD LSR-X20 and, most recently, a 5-laser BD LSR-X50. Of these digital instruments, the first 3 are capable of up to 18-24 parameter single cell analyses, while the X50 is capable of supporting 50-parameter flow cytometry. To provide comprehensive immunologic support, we have implemented several highly developed components for the IPC. A specimen processing and biobanking service that began at Emory under Dr. Kirk has been re-established as the Substrate Services and Research Support Service (SSCRSS) at Duke following his arrival as Chairman of the Department of Surgery. Through the work of Dr. Kirk's laboratory, we have also established a viral testing facility that will allow the IPC to monitor three of the most clinically-relevant latent viruses in NHPs: Rhesus Cytomegalovirus (rhCMV), Rhesus Lymphocryptovirus (rhLCV) (rhesus homology of EBV), and Simian Virus 40 (SV40). The IPC will provide routine histology and immunohistochemistry assays through our immunohistochemistry service laboratory, which will allow each project to examine the effects of the experimental manipulations on key host tissue. Special emphasis will be placed on examining effects on germinal center formation following the various induction regimens. The juxtaposition of human and NHP expertise represents a particular strength of this IPC consortium, further facilitating the highly translational aspects of the proposed studies
免疫分析核心(IPC)将为构成U19提案的两个项目中提出的假设驱动的研究提供全面的技术分析支持服务。核心的最大综合实力来自其各组成部分的相关专门知识、组织、程序和业务协同作用。支持这些努力的是杜克免疫分析核心(DIPC),这是自1988年以来一直存在的杜克医学院共享资源。Core专注于基于流式细胞仪的人类免疫分析平台,25年来一直积极参与外部能力验证和质量保证计划。根据高度标准化和经验证的标准操作规程(SOP),在符合药物临床试验质量管理规范(GCLP)的环境中进行含量测定。该核心是由一个支持团队的经验丰富的实验室专业人员从柯克和克奈希特尔研究核心谁最近重新定位到杜克从埃默里大学的努力。这些人在移植研究的各个方面都有广泛的专业知识,包括人类和非人灵长类动物(NHP)研究。IPC将为项目1和2提供的主要服务包括:1)最先进的标本处理和生物库,2)分析多色流式细胞术(PFC)表型分析和细胞内细胞因子染色(ICCS),3)病毒学检测,以及4)全面的组织学和免疫组织化学支持。IPC完全有能力为本提案下的项目提供PFC服务; PFC一直是DIPC研究工作的技术支柱。目前的核心设施包括4激光BD LSRII、5激光BD LSRFortessa、5激光BD LSR-X20以及最近的5激光BD LSR-X50。在这些数字仪器中,前3种能够进行多达18-24个参数的单细胞分析,而X50能够支持50个参数的流式细胞术。为了提供全面的免疫支持,我们为IPC实现了几个高度开发的组件。柯克博士在埃默里大学开始的标本处理和生物库服务在他担任外科系主任后被重新建立为杜克大学的基质服务和研究支持服务(SSCRSS)。通过Kirk博士实验室的工作,我们还建立了一个病毒检测设施,使IPC能够监测NHP中三种最具临床相关性的潜伏病毒:恒河猴巨细胞病毒(rhCMV)、恒河猴淋巴腺病毒(rhLCV)(EBV的恒河猴同源性)和猿猴病毒40(SV 40)。IPC将通过我们的免疫组织化学服务实验室提供常规组织学和免疫组织化学测定,这将允许每个项目检查实验操作对关键宿主组织的影响。特别强调的是,将放在检查后的各种诱导方案对生发中心形成的影响。人类和NHP专业知识的并列代表了IPC联盟的特殊优势,进一步促进了拟议研究的高度转化方面
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kent J. Weinhold其他文献
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors.
来自人类免疫缺陷病毒血清阳性供体的 IgG 静脉注射溶液的制备和表征。
- DOI:
10.1182/blood.v77.5.1111.bloodjournal7751111 - 发表时间:
1991 - 期刊:
- 影响因子:20.3
- 作者:
Larry M. Cummins;Kent J. Weinhold;Thomas J. Matthews;A. J. Langlois;C. F. Perno;RICHARD M. Condie;Jean - 通讯作者:
Jean
Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.
HIV 包膜糖蛋白中和单克隆抗体的特征。
- DOI:
- 发表时间:
1988 - 期刊:
- 影响因子:1.5
- 作者:
Michael A. Skinner;Robert Ting;A. J. Langlois;Kent J. Weinhold;H. K. Lyerly;K. Javaherian;Thomas J. Matthews - 通讯作者:
Thomas J. Matthews
3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase
3-叠氮基-3-脱氧胸苷三磷酸作为纯化人免疫缺陷病毒逆转录酶的抑制剂和底物
- DOI:
10.1128/aac.31.12.1972 - 发表时间:
1987 - 期刊:
- 影响因子:4.9
- 作者:
M. H. S. Clair;Cynthia A. Richards;Thomas Spector;Kent J. Weinhold;Wayne H. Miller;A. J. Langlois;Phillip A. Furman - 通讯作者:
Phillip A. Furman
Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.
抗 HIV-1 ADCC 的直接和间接形式的测量:对其他逆转录病毒疾病的影响。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
Kent J. Weinhold;Douglas S. Tyler;H. K. Lyerly - 通讯作者:
H. K. Lyerly
Coupling Hematoma Evacuation with Immune Profiling for Analysis of Neuroinflammation After Primary Intracerebral Hemorrhage: A Pilot Study
- DOI:
10.1016/j.wneu.2022.02.062 - 发表时间:
2022-05-01 - 期刊:
- 影响因子:
- 作者:
Jay B. Lusk;Quintin J. Quinones;Janet S. Staats;Kent J. Weinhold;Peter M. Grossi;Shahid M. Nimjee;Daniel T. Laskowitz;Michael L. James - 通讯作者:
Michael L. James
Kent J. Weinhold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kent J. Weinhold', 18)}}的其他基金
Biorepository, Pathology, and Immune Monitoring Core
生物样本库、病理学和免疫监测核心
- 批准号:
10248315 - 财政年份:2014
- 资助金额:
$ 26.01万 - 项目类别:
Biorepository, Pathology, and Immune Monitoring Core
生物样本库、病理学和免疫监测核心
- 批准号:
10705239 - 财政年份:2014
- 资助金额:
$ 26.01万 - 项目类别:
相似海外基金
Rationally guided discovery platform for monoclonal antibodies against carbohydrate antigens using virus-like particle conjugate immunization and high throughput selection
使用病毒样颗粒缀合物免疫和高通量选择的合理引导的针对碳水化合物抗原的单克隆抗体的发现平台
- 批准号:
10574738 - 财政年份:2023
- 资助金额:
$ 26.01万 - 项目类别:
Assessing the role of liver stage antigens-specific antibodies against Plasmodium falciparum liver stage infection
评估肝期抗原特异性抗体对抗恶性疟原虫肝期感染的作用
- 批准号:
10392870 - 财政年份:2021
- 资助金额:
$ 26.01万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
10092930 - 财政年份:2020
- 资助金额:
$ 26.01万 - 项目类别:
Generation of antibodies specific for optimal non-HRP2 malaria diagnostic antigens
生成最佳非 HRP2 疟疾诊断抗原的特异性抗体
- 批准号:
9896170 - 财政年份:2020
- 资助金额:
$ 26.01万 - 项目类别:
Interrogation of cell surface antigens on B lineage cells using structurally unique variable lymphocyte receptor antibodies of the evolutionarily distant sea lamprey
使用进化遥远的海七鳃鳗结构独特的可变淋巴细胞受体抗体询问 B 谱系细胞上的细胞表面抗原
- 批准号:
433456 - 财政年份:2020
- 资助金额:
$ 26.01万 - 项目类别:
Operating Grants
Investigations of interactions between various natural antibodies and food-derived antigens
研究各种天然抗体与食物源性抗原之间的相互作用
- 批准号:
19K15765 - 财政年份:2019
- 资助金额:
$ 26.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Identifying Kawasaki Disease-Specific Antibodies and Antigens
识别川崎病特异性抗体和抗原
- 批准号:
9932769 - 财政年份:2018
- 资助金额:
$ 26.01万 - 项目类别:
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
BB/P504713/1 - 财政年份:2017
- 资助金额:
$ 26.01万 - 项目类别:
Training Grant
Novel Scoring Methods for Interactions between Antibodies and Antigens
抗体和抗原之间相互作用的新评分方法
- 批准号:
1932904 - 财政年份:2017
- 资助金额:
$ 26.01万 - 项目类别:
Studentship
SBIR Phase II: Automated Design Methods of Antibodies Directed to Protein and Carbohydrate Antigens
SBIR II 期:针对蛋白质和碳水化合物抗原的抗体的自动化设计方法
- 批准号:
1632399 - 财政年份:2016
- 资助金额:
$ 26.01万 - 项目类别:
Standard Grant














{{item.name}}会员




